Authors:
Noone, PG
Hamblett, N
Accurso, F
Aitken, ML
Boyle, M
Dovey, M
Gibson, R
Johnson, C
Kellerman, D
Konstan, MW
Milgram, L
Mundahl, J
Retsch-Bogort, G
Rodman, D
Williams-Warren, J
Wilmott, RW
Zeitlin, P
Ramsey, B
Citation: Pg. Noone et al., Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: Results of a phase I multi-center study, PEDIAT PULM, 32(2), 2001, pp. 122-128
Citation: Kw. Southern et al., A modified technique for measurement of nasal transepithelial potential difference in infants, J PEDIAT, 139(3), 2001, pp. 353-358
Citation: Pg. Noone et al., Cystic fibrosis gene mutations and pancreatitis risk: Relation to epithelial ion transport and trypsin inhibitor gene mutations, GASTROENTY, 121(6), 2001, pp. 1310-1319
Authors:
Noone, PG
Hohneker, KW
Zhou, ZQ
Johnson, LG
Foy, C
Gipson, C
Jones, K
Noah, TL
Leigh, MW
Schwartzbach, C
Efthimiou, J
Pearlman, R
Boucher, RC
Knowles, MR
Citation: Pg. Noone et al., Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis, MOL THER, 1(1), 2000, pp. 105-114
Citation: Ja. Regnis et al., Prolonged airway retention of insoluble particles in cystic fibrosis versus primary ciliary dyskinesia, EXP LUNG R, 26(3), 2000, pp. 149-162
Authors:
Noone, PG
Bennett, WD
Regnis, JA
Zeman, KL
Carson, JL
King, M
Boucher, RC
Knowles, MR
Citation: Pg. Noone et al., Effect of aerosolized uridine-5 '-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia, AM J R CRIT, 160(1), 1999, pp. 144-149